Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
Eli Lilly And Co (NYSE:LLY) announced a $3 billion expansion of its Kenosha County, Wisconsin, manufacturing facility to ...
SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue viewing our website.Digital subscribers receiveUnlimited access to all stories ...
The latest Zepbound data bodes well for Lilly and could help establish the drug as the new standard for obesity medications.
The purchase price of the facility was not disclosed, but Lilly says its new $3 billion investment – part of $23 billion ...
The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...
Eli Lilly LLY recently announced its plans to spend $3 billion to expand the manufacturing facility in Wisconsin that was ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The top China executive of US pharmaceutical company Eli Lilly and Co said on Wednesday that the company aims to make its ...
The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall ...
As the project moves forward here is some basic information about the company and the proposed $3 billion development itself.
Lilly announced in April that it agreed to acquire the manufacturing facility from Nexus Pharmaceuticals LLC. The acquisition ...